Biophytis (EPA:ALBPS) | Finanzwire

Basculer en Français

8302	Companies
115129	Keywords
55450	Articles
62533	Press releases

Home
Companies
Biophytis

BRIEF

published on 04/29/2024 at 07:05, 6 months 22 days ago

Biophytis Advances Partnership Strategy in Obesity Sector

Biophytis Obesity Treatment Healthcare Innovation Pharmaceutical Partnerships BIO101
REGULATED PRESS RELEASE

published on 04/29/2024 at 07:00, 6 months 22 days ago

Biophytis is deploying its partnership strategy in obesity
Biophytis announces partnership strategy for obesity, aiming to license out drug candidate BI0101 to global pharma companies for development, launch, and commercialization. CEO stresses importance of partnering for medical innovation

Biophytis Medical Innovation Obesity Partnership Strategy Drug Candidate
BRIEF

published on 04/24/2024 at 23:05, 6 months 27 days ago

Biophytis Transfers ADSs to OTC Market Following Nasdaq Delisting

Biophytis Euronext Growth Nasdaq Delisting OTC Market Stockholders' Equity
PRESS RELEASE

published on 04/24/2024 at 23:00, 6 months 27 days ago

Biophytis Announces Transfer of ADSs to OTC Market
Biophytis announces transfer of ADSs to OTC market, resulting in cost savings. ADSs to trade on OTC Pink, while applying for OTCQB. Company remains listed on Euronext Growth Paris

Euronext Growth Paris Biophytis Nasdaq OTC Market ADSs
REGULATED PRESS RELEASE

published on 04/24/2024 at 23:00, 6 months 27 days ago

Biophytis Announces Transfer of ADSs to OTC Market
Biophytis announces the transfer of ADSs from Nasdaq to OTC Market, resulting in cost savings. Company to trade on OTCQB while remaining listed on Euronext Growth Paris

Euronext Growth Paris Biophytis Nasdaq OTC Market ADSs
BRIEF

published on 04/19/2024 at 07:05, 7 months 2 days ago

Biophytis Announces Significant Change in ADR Program Ratio

Biophytis Biotechnology Nasdaq ADR Program Stock Ratio Change
PRESS RELEASE

published on 04/19/2024 at 07:00, 7 months 2 days ago

Biophytis announces ratio change under its American Depositary Receipt (“ADR”) program
Biophytis announces ratio change for its American Depositary Receipt (ADR) program, with effective date expected to be April 23, 2024

Biophytis Stock Market American Depositary Receipt ADR Program Ratio Change
REGULATED PRESS RELEASE

published on 04/19/2024 at 07:00, 7 months 2 days ago

Biophytis announces ratio change under its American Depositary Receipt (“ADR”) program
Biophytis announces ratio change for its American Depositary Receipt program, affecting ADS to Shares ratio. No new shares issued, trading price may increase. Details provided in the press release

Biophytis Shares Ads American Depositary Receipt Ratio Change
BRIEF

published on 04/18/2024 at 07:05, 7 months 3 days ago

Biophytis Announces New Scientific Advisory Board for Phase 2 Obesity Study

Biophytis Scientific Advisory Board BIO101 Obesity OBA Clinical Study
PRESS RELEASE

published on 04/18/2024 at 07:02, 7 months 3 days ago

Biophytis announces new Scientific Advisory Board for its phase 2 OBA clinical study in obesity
Biophytis appoints new Scientific Advisory Board for phase 2 OBA clinical study in obesity with Prof. Dennis Villareal and Prof. Francisco Guarner. IND filing with FDA soon

FDA Biophytis Scientific Advisory Board Obesity OBA Clinical Study

Accesswire

Published on 11/22/2024 at 00:00, 5 hours 48 minutes ago

Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 7 hours 43 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 7 hours 58 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 9 hours 33 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 9 hours 38 minutes ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 19:01, 10 hours 46 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 11 hours 12 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 11 hours 49 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 11 hours 56 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 11 hours 56 minutes ago

2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.

Les Echos

Published on 11/21/2024 at 06:58, 22 hours 50 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 10 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 12 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 12 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 22 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE